Professional Documents
Culture Documents
General Notices
7.5 per cent V/V of formamide R in acetone R so that the plate dips about 5 mm
beneath the
surface of the liquid. When the impregnation mixture has risen at least 17 cm from the
lower
edge of the plate, remove the plate and use immediately for chromatography. Carry out
the
chromatography in the same direction as the impregnation.
Test solutionDissolve 20 mg of the substance to be examined in chloroform R and
dilute to
10 ml with the same solvent.
Reference solutionDissolve 20 mg of perphenazine CRS in chloroform R and
dilute to 10 ml
with the same solvent.
Apply separately to the plate 2 l of each solution. Develop in the dark over a path of 15
cm
using a mixture of 2 volumes of diethylamine R and 100 volumes of light petroleum
R,
saturated with phenoxyethanol (add phenoxyethanol R - 6 volumes to 8 volumes - to
the
above mixture of solvents until there is a persistent cloudiness after shaking, decant,
and use
the supernatant liquid, even if it is cloudy). Expose the plate to ultraviolet light at 365 nm
and
examine after a few minutes. The principal spot in the chromatogram obtained with the
test
solution is similar in position, fluorescence and size to the principal spot in the
chromatogram
obtained with the reference solution. Dry the plate at 120 C for 20 min, allow to cool
and
spray with a 10 per cent V/V solution of sulphuric acid R in alcohol R. The principal
spot in the
chromatogram obtained with the test solution is of the same colour as the principal spot
in the
chromatogram obtained with the reference solution.
TESTS
Appearance of solution
Dissolve 0.20 g in 10 ml of methanol R. The solution is clear (2.2.1).
Related substances
Perphenazine Tablets
General Notices
IDENTIFICATION
A. To a quantity of the powdered tablets containing 40 mg of Perphenazine add 10 ml
of
water and 2 ml of 1M sodium hydroxide, shake and extract with 15 ml of ether .
Wash the
ether layer with 5 ml of water, dry with anhydrous sodium sulphate and evaporate
the ether
to dryness. The infrared absorption spectrum of the residue, Appendix II A, is
concordant
with the reference spectrum of perphenazine (RS 265).
B. Extract a quantity of the powdered tablets containing 20 mg of Perphenazine with 10
ml of
chloroform, filter and evaporate the filtrate to dryness. Dissolve the residue in 2 ml of
methanol , pour into a solution of 0.4 g of picric acid in 10 ml of methanol at 50,
cool and
allow to stand for 4 hours. The melting point of the precipitate, after recrystallisation
from
methanol , is about 248, with decomposition, Appendix V A.
C. To a quantity of the powdered tablets containing 5 mg of Perphenazine add 5 ml of
sulphuric acid and allow to stand for 5 minutes. A red colour is produced.
TESTS
Related substances
Comply with the test for related substances in phenothiazines, Appendix III A,
using mobile
phase C and applying separately to the plate 50 l of each of the following freshly
prepared
solutions. For solution (1) extract a quantity of the powdered tablets containing 20 mg of
Perphenazine with 10 ml of ethanol (96%) and filter. For solution (2) dilute 1 volume of
solution (1) to 200 volumes with ethanol (96%).
Uniformity of content
Tablets containing 2 mg or less of Perphenazine comply with the requirements stated
under
Tablets using the following method of analysis. Carry out the following procedure
protected
from light. Record second-derivative ultraviolet absorption spectra of the
following solutions,
Appendix II B, in the range 210 to 290 nm. For solution (1) add 5 ml of water to one
tablet,
mix with the aid of ultrasound for 15 minutes or until the tablet has completely
disintegrated, heat on a water bath for 3 minutes, swirling continuously and cool. Add 50
ml of ethanol
(96%), mix with the aid of ultrasound for 2 minutes, shake for 5 minutes, dilute to 100 ml
with
ethanol (96%) and filter through a glass microfibre filter paper. Dilute the filtrate, if
necessary,
with ethanol (96%) to produce a solution containing 0.001% w/v of Perphenazine.
Solution (2)
contains 0.001% w/v of perphenazine BPCRS in ethanol (96%).
For each solution measure the amplitude from the peak at 265 nm to the trough at 255
nm.
Calculate the content of C21H26N3OS in each tablet using the declared content of
C21H26N3OS
in perphenazine BPCRS.
ASSAY
For tablets containing more than 2 mg of Perphenazine
Carry out the following procedure protected from light. Record second-derivative
ultraviolet
absorption spectra of the following solutions, Appendix II B, in the range 210 to 290
nm. For
solution (1) add 50 ml of water to 10 tablets, mix with the aid of ultrasound for 15
minutes or
until the tablets have completely disintegrated, heat on a water bath for 3 minutes,
swirling
continuously, cool, add 400 ml of ethanol (96%), mix with the aid of ultrasound for 2
minutes,
shake for 5 minutes, dilute to 500 ml with ethanol (96%) and filter through a glass
microfibre
filter paper. Dilute the filtrate with ethanol (96%) to produce a solution containing
0.001% w/v
of Perphenazine. Solution (2) contains 0.001% w/v of perphenazine BPCRS in
ethanol (96%).
Measure the amplitude from the peak at 265 nm to the trough at 255 nm. Calculate the
content of C21H26N3OS using the declared content of C21H26N3OS in perphenazine
BPCRS.
For tablets containing 2 mg or less of Perphenazine
Use the average of the 10 individual results obtained in the test for Uniformity of content.
perphenazine
Pemberitahuan umum
(Ph Eur monografi 0629)
C21H26ClN3OS404.058-39-9
Aksi dan penggunaan
Antagonis reseptor dopamin; neuroleptik.
persiapan
Tablet perphenazine
DEFINISI
Perphenazine mengandung tidak kurang dari 99,0 persen dan tidak lebih dari setara
dengan 101,0
persen dari 2 - [4 - [3 - (2-chlorophenothiazin-10-il) propil] piperazin-1-yl] etanol,
dihitung dengan
referensi untuk bahan kering.
KARAKTER
A putih atau putih kekuningan, bubuk kristal, praktis tidak larut dalam air, bebas
larut dalam
metilen klorida, larut dalam alkohol. Larut dalam larutan encer asam klorida.
IDENTIFIKASI
Pertama identificationA, C
Kedua identificationA, B, D.
Ia. Titik lebur (2.2.14): 96 C sampai 100 C.
IB. Larutkan 10 mg dalam metanol R dan encerkan sampai 100 ml dengan pelarut
yang sama. Encerkan 10 ml
solusi untuk 100 ml dengan metanol R. Diperiksa antara 230 nm dan 350 nm
(2.2.25),
solusi menunjukkan dua maxima penyerapan, pada 257 nm dan 313 nm. Rasio
absorbansi diukur pada maksimum pada 313 nm sampai yang diukur pada
maksimum pada 257nm adalah 0,120-0,128.
Lampiran II B, di kisaran 210-290 nm. Untuk solusi (1) tambahkan 5 ml air untuk
satu tablet,
mencampur dengan bantuan USG selama 15 menit atau sampai tablet telah benarbenar hancur, panas pada air mandi selama 3 menit, berputar-putar terus menerus
dan sejuk. Tambahkan 50 ml etanol
(96%), campuran dengan bantuan USG selama 2 menit, kocok selama 5 menit,
encerkan sampai 100 ml dengan
etanol (96%) dan filter melalui microfibre kaca kertas saring. Encerkan filtrat, jika
perlu,
dengan etanol (96%) untuk menghasilkan larutan yang mengandung 0,001% b / v
dari Perphenazine. Solusi (2)
mengandung 0,001% b / v dari BPCRS perphenazine dalam etanol (96%).
Untuk setiap solusi mengukur amplitudo dari puncak pada 265 nm sampai palung
pada 255 nm.
Hitung isi C21H26N3OS di setiap tablet menggunakan konten menyatakan dari
C21H26N3OS
di BPCRS perphenazine.
ASSAY
Untuk tablet yang mengandung lebih dari 2 mg Perphenazine
Melaksanakan prosedur berikut terlindung dari cahaya. Rekam ultraviolet keduaderivatif
spektrum penyerapan solusi berikut, Lampiran II B, di kisaran 210-290 nm. untuk
Solusi (1) tambahkan 50 ml air sampai 10 tablet, campuran dengan bantuan USG
selama 15 menit atau
sampai tablet telah benar-benar hancur, panas pada air mandi selama 3 menit,
berputar-putar
terus menerus, dingin, tambahkan 400 ml etanol (96%), campuran dengan bantuan
USG selama 2 menit,
kocok selama 5 menit, encerkan sampai 500 ml dengan etanol (96%) dan
menyaring melalui microfibre kaca
kertas saring. Encerkan filtrat dengan etanol (96%) untuk menghasilkan larutan
yang mengandung 0,001% b / v